Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
about
X region mutations of hepatitis B virus related to clinical severityDNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma.Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutationsPrognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma.Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV.Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.Specific in situ hepatitis B viral double mutation (HBVDM) detection in urine with 60 copies ml(-1) analytical sensitivity in a background of 250-fold wild type without DNA isolation and amplification.Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.Clinical and virological implications of A1846T and C1913A/G mutations of hepatitis B virus genome in severe liver diseases.
P2860
Q26746928-CDA2A6DD-197D-45C8-9519-FA97DED5172DQ27336155-3D7DAE8C-61C8-4B40-9E1A-A36CECA499B3Q30251618-817D0563-FE2A-476C-A0B7-D5FF8D72B173Q30908240-0EAFD608-A547-41B0-8B6D-233EECFBC37BQ36227142-D1A13C06-1A08-4FA8-928A-4B6B66C2FD66Q37254285-5C660E88-0DD2-4D4C-8247-B356AC66F9C9Q38869839-3D51D11A-08BD-46C8-BB8F-E0D249DA3F88Q39171907-3D249DE1-4BD5-41B4-A014-937CC6074D41Q39367201-4D45D262-AC65-41AA-B9BC-EF149B1DC76AQ39428108-CED75903-A08A-4DF8-BAC6-5BD250DAB9A2Q40311544-9D305FDD-AD3B-4CEE-A2D1-DF30FCC4924CQ42174683-AE6AD4E9-D09C-47FA-B1A7-06186109F5DBQ42436025-9A44C554-C6D6-4193-8795-08F653663C52Q47555493-64FDE7E9-E6E1-4EE7-86AD-BDD9B0361536
P2860
Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@ast
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@en
type
label
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@ast
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@en
prefLabel
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@ast
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@en
P2093
P2860
P356
P1433
P1476
Predictive power of hepatitis ...... rcinoma risk in Qidong, China.
@en
P2093
Alvaro Muñoz
Jamie L Johnson
Jian Guo Chen
Jian Hua Lu
Jin-Bing Wang
John D Groopman
Melinda L Marshall
Michael F Schneider
Patricia A Egner
Tao Yang Chen
P2860
P304
P356
10.1093/CARCIN/BGR055
P407
P577
2011-04-07T00:00:00Z